A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Na ïve or Insulin Treated Subjects With T2DM

Conditions: Type 2 Diabetes Interventions: Drug: GZR101; Drug: insulin degledec/insulin aspart Sponsors: Gan and Lee Pharmaceuticals, USA Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials